rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Acadia Healthcare Company, Inc.

ACHC · Nasdaq

Health CareProviders & FacilitiesJust started moving

ACHC stood above a rising 150-day average in 31 of the last 52 weekly readings, including each of the last 31 weeks. It is 8.4% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
31 in a row
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
12
Institutions holding
290 (+20)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 31 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

12 disclosed lines: House 12, Senate 0, executive 0; 3 people.

WhoDidAmountTraded
Susie Lee House: U.S. House ClerkNV03soldjoint$1k–$15k30 Nov 2022filed 29 Dec 2022
Peter Meijer House: U.S. House ClerkMI03sold$1k–$15k16 Feb 2021filed 16 Mar 2021
James B. Renacci House: U.S. House ClerkOH16sold$15k–$50k15 Dec 2017filed 21 Dec 2017
James B. Renacci House: U.S. House ClerkOH16bought$15k–$50k13 Jan 2017filed 24 Jan 2017
James B. Renacci House: U.S. House ClerkOH16sold$15k–$50k13 Dec 2016filed 20 Dec 2016
James B. Renacci House: U.S. House ClerkOH16sold$1k–$15k24 Oct 2016filed 7 Nov 2016
James B. Renacci House: U.S. House ClerkOH16sold$1k–$15k4 Jan 2016filed 27 Jan 2016
James B. Renacci House: U.S. House ClerkOH16sold$1k–$15k4 Aug 2015filed 25 Aug 2015
James B. Renacci House: U.S. House ClerkOH16sold$1k–$15k8 Apr 2015filed 22 Apr 2015
James B. Renacci House: U.S. House ClerkOH16bought$1k–$15k25 Feb 2015filed 4 Mar 2015
James B. Renacci House: U.S. House ClerkOH16bought$1k–$15k4 Nov 2014filed 20 Nov 2014
James B. Renacci House: U.S. House ClerkOH16bought$15k–$50k10 Jan 2014filed 27 Jan 2014

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders290+20 on the quarter
New · exited69 · 48
Reported value$4.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202614,957,168$441.7M+3,270,779+28.0%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 20265,726,246$169.1M-3,346,696−36.9%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20265,369,461$158.6M+308,023+6.1%
FMR LLCreduced · filed 13 Aug 20265,015,727$148.1M-1,851,951−27.0%
CARRONADE CAPITAL MANAGEMENT, LPadded · filed 14 Aug 20264,762,635$140.6M+2,425,399+103.8%
MORGAN STANLEYadded · filed 13 Aug 20264,534,269$133.9M+43,202+1.0%
DEERFIELD MANAGEMENT COMPANY, L.P.unchanged · filed 14 Aug 20264,520,000$133.5M00.0%
DME Capital Management, LPreduced · filed 14 Aug 20264,400,641$130.0M-117,740−2.6%
FARALLON CAPITAL MANAGEMENT, L.L.C.added · filed 14 Aug 20264,220,800$124.6M+2,484,000+143.0%
ABRAMS BISON INVESTMENTS, LLCreduced · filed 14 Aug 20264,165,000$123.0M-215,000−4.9%
31 Mar 2023 – 30 Jun 2026
227258288Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Brian Farley Company insiderEVP, CLAO and Secretary · last 26 Jul 20260 · 0
Daniel J. Cancelmi Company insiderDirector · last 6 May 20260 · 0
E. Perot Bissell Company insiderDirector · last 6 May 20260 · 0
Jason Bernhard Company insiderDirector · last 6 May 20260 · 0
Michael Fucci Company insiderDirector · last 6 May 20260 · 0
Patrice A. Harris Company insiderDirector · last 6 May 20260 · 0
Ralph David Kelly Company insiderDirector · last 6 May 20260 · 0
Reeve B. Waud Company insiderDirector · last 6 May 20261 · 32
Vicky B. Gregg Company insiderDirector · last 6 May 20260 · 1
William Grieco Company insiderDirector · last 6 May 20260 · 16
Todd S. Young Company insiderChief Financial Officer · last 10 Apr 20260 · 0
Debra K. Osteen Company insiderChief Executive Officer · last 20 Jan 20261 · 3

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Free cash flow marginFY 2025 · to 31 Dec 2025-13.3%
Debt to equityFY 2025 · to 31 Dec 20251.30×
Share count trendFY 2025 · to 25 Feb 20261.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$133.2M
Free cash flowFY 2025 · to 31 Dec 2025−$439.9M

Analyst forecasts

No analyst forecasts yet.